Development
C
Semler Scientific, Inc. SMLR
$30.02 -$1.41-4.49% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

12/31/2023 09/30/2023 06/30/2023 03/31/2023 12/31/2022
Net Income 43.69% 55.18% 35.51% 1.46% -16.82%
Total Depreciation and Amortization 1.70% -8.71% -10.85% -10.35% -6.21%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 342.09% -26.53% -59.44% -77.89% -68.43%
Change in Net Operating Assets -323.83% -217.06% 162.50% 96.50% 136.48%
Cash from Operations 22.14% 6.82% 27.97% 29.88% 8.76%
Capital Expenditure 61.67% -20.48% -70.95% -191.79% -161.82%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 177.91% -1,820.78% -1,258.52% -31,892.54% --
Cash from Investing 168.55% -792.04% -633.94% -5,102.66% -3,152.73%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -69.64% 2.06% 12.94% -4.50% 189.66%
Repurchase of Common Stock 31.24% 95.20% 28.54% -1,918.40% -11,244.44%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -9.54% 58.50% -34.85% -3,453.96% -38,076.92%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 339.84% -183.69% -104.65% -377.21% -193.87%